stop_circleTerminated/Withdrawn
Rhinitis, Allergic
Bayer Identifier:
18573
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Exploratory study for allergy relief onset
Trial purpose
The purpose of the study is to explore the onset of effect of an antihistamine in a controlled environment.
Key Participants Requirements
Sex
BothAge
18 - 65 YearsTrial summary
Enrollment Goal
1Trial Dates
May 2016 - July 2016Phase
Phase 2Could I Receive a placebo
YesProducts
chlorpheniramine maleate (BAYX002134)Accepts Healthy Volunteer
NoWhere to participate
Status | Institution | Location |
---|---|---|
Terminated | Germantown, 38138, United States |
Primary Outcome
- The time to the meaningful relief, as defined by at least 15% of reduction from baseline in Total Symptom Score (TSS)date_rangeTime Frame:4 hoursenhanced_encryptionNoSafety Issue:
Secondary Outcome
- Number of patients with adverse events as a measure of safetydate_rangeTime Frame:3 monthenhanced_encryptionYesSafety Issue:
Trial design
Trial Type
InterventionalIntervention Type
DrugTrial Purpose
TreatmentAllocation
RandomizedBlinding
Single BlindAssignment
Crossover AssignmentTrial Arms
2